Return On Equity ratio Analysis of Eagle Pharmaceuticals Inc - Deep Dive
Latest FY ROE
Period Ending - Dec-22
Good ROE
15.26
Period Ending - Dec-21
Very Poor ROE
-0.266
Growth
5841.43 %
Trailing Twelve Months ROE
Period Ending - Dec-22
Not Good ROE
6.48
Most recent Quarter ROE
Period Ending - Jun-23
Not Good ROE
2.05
ROE Analysis of Eagle Pharmaceuticals Inc
ROE Ratio of EGRX rose handsomely by 5841.43 % this year. |
ROE Ratio with value of 19.84 was highest in Year Dec-18 in last Five Years. |
ROE Ratio with value of -0.266 was lowest in Year Dec-21 in last Five Years. |
Latest ROE Ratio with value of 15.26 is Greater than Average ROE of 9.85 in last five years. |
Other ROE Related Info of EGRX that may interest you.
Eagle Pharmaceuticals Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
EGRX | 4.06 | 3.85 | 5.45 % | Drug Manufacturers-Specialty & Generic |
Defination of Return On Equity
The Return on Equity (ROE) is a profitability metric that measures a company's ability to generate profits using its shareholder's fund. ROE is calculated by dividing Net Income by Shareholders' Fund. more ..ROE Related Ratios
ReturnOnAsset | NetProfitMargin |
Tsr Profitability Index
No Significant Profitability |
FY - Historical Return On Equity of Eagle Pharmaceuticals Inc
Period | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
---|---|---|---|---|---|---|---|
ROE | 15.26 | -0.266 | 6.45 | 7.99 | 19.84 | 29.00 | 53.86 |
Change | 5841.43 % | -104.12 % | -19.32 % | -59.75 % | -31.56 % | -46.17 % | 1792.66 % |
FY Chart of Return On Equity of Eagle Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)